Skip to content

An exploratory study to investigate the effect of FE 999302 when given during different time periods to women undergoing controlled ovarian stimulation with follitropin delta

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508149-42-00
Acronym
000427
Enrollment
201
Registered
2024-06-17
Start date
2024-07-16
Completion date
2025-09-05
Last updated
2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility in women undergoing assisted reproductive technologies (ART)

Interventions

None listed

Sponsors

Ferring Pharmaceuticals A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium, Czechia, Denmark, Norway, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026